How to create a therapeutics committee that is scientifically and economically sound

Formulary

Volumn 38, Issue 10, 2003, Pages 594-602

  Quintiliani, Richard ^a,b   Quercia, Robert A ^b,c  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

^c HARTFORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COST EFFECTIVENESS ANALYSIS; DRUG INFORMATION; HEALTH CARE DELIVERY; HEALTH CARE PERSONNEL; HOSPITAL CARE; HOSPITAL PHARMACY; REVIEW;

EID: 0141885315     PISSN: 1082801X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (8)

1. Richerson MA, Ambrose PG, Bui KQ, et al. Pharmacokinetic and economic evaluation of piperacillin/tazobactam administered as either continuous or intermittent infusion with once-daily gentamicin. IDCP. 1999;8:195-200.
2. Nicolau DP, Freeman CD, Belliveau PP, et al. Experience with a once-daily aminoglycoside program administered to 2,184 adult patients. Antimicrob Agents Chemother. 1995;39:650-655.
3. Quintiliani R. Strategies for the cost-effective use of antibiotics. In: Gorbach, Bartlett, Blaklow, eds. Infectious Disease, Part IV: Treatment of Infectious Disease. Philadelphia, PA: W.B. Saunders Co, 1998.
4. McNabb JC, Quintiliani P, Nicolau D, Grant E, Nightingale CH. Cost effectiveness in the use of antibiotics. Curr Clin Top Infect Dis. 2000;20:24-42.
5. Craig WA. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin Infect Dis. 1998;26:1-12.
6. Daluiski A, Kuhns CA, Jackson KR, Lieberman, JR. Publication rate of abstracts presented at the annual meeting of the Orthopaedic Research Society, J Orthop Res. 1998;16:643-644.
7. Milkovich G. Intravenous-to-oral transition therapy in community-acquired pneumonia: the INOVA Health System experience. Pharmacotherapy. 2001;21 (pt 2):83S-88S.
8. Kuti JL, Le TN, Nightingale CH, Nicolau DP, Quintiliani R. Pharmacoeconomics of a pharmacist-managed program for automatically converting levofloxacin route from IV to oral. Am J Health-Syst Pharm. 2002;59:2209-2215.